Twist Bioscience (TWST) Shares Outstanding (Weighted Average) (2017 - 2026)

Twist Bioscience (TWST) has 10 years of Shares Outstanding (Weighted Average) data on file, last reported at $61.4 million in Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $61.4 million, up 3.34% year-over-year; the trailing twelve-month figure through Mar 2026 was $61.4 million (up 3.34% YoY), and the FY2025 annual result was $59.8 million, up 3.09% from the prior year.
• Shares Outstanding (Weighted Average) improved to $61.4 million in Q1 2026 per TWST's latest filing, from $61.1 million in the prior quarter.
• Over five years, Shares Outstanding (Weighted Average) peaked at $61.4 million in Q1 2026 and troughed at $53.0 million in Q2 2022.
• A 5-year average of $57.6 million and a median of $57.8 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
• The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Weighted Average) grew 13.09% in 2022, then climbed 1.76% in 2024.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $56.4 million in 2022, then climbed by 1.87% to $57.5 million in 2023, then increased by 2.9% to $59.2 million in 2024, then increased by 3.24% to $61.1 million in 2025, then rose by 0.5% to $61.4 million in 2026.
• Business Quant data shows TWST's Shares Outstanding (Weighted Average) at $61.4 million in Q1 2026, $61.1 million in Q4 2025, and $59.8 million in Q3 2025.